National Security Council (NSC) wants India to follow the UK system of testing mobile equipment for bugs and give ?safe?…
The proposal for price negotiation of patented drugs is being revisited by the government.
The initial hype over Indian drug makers venturing into new drug discovery more than a decade ago seems to have…
India wants the European Union to stop disrupting its shipment of generic drugs in transit to third countries in West…
Drug majors Eli Lilly, Novo Nordisk, Torrent Pharma and Lupin may not be allowed to hike insulin rates as they…
Any telecom gear marked ‘security sensitive’ should be 100% made-in-India, the department of telecom (DoT) has told the Prime Minister’s…
Dr Reddy?s Laboratories (DRL), India?s second-largest drug maker, could get a first to file para IV status on its drug…
Prime minister Manmohan Singh has approved the constitution of a group of ministers to look into reviving the ailing telecom…
Telecom department has decided to form a panel to study viability gap funding options for subsidising the Rs33,000-crore ‘green’ mobile…
The upcoming drug policy regime where a market-based formula will be used to cap prices of around 650 formulations
The Department of Telecommunications plans to notify the final rules for obtaining and migrating to a unified licence by end…
To revive the ailing telecom PSUs such as BSNL and MTNL, telecom minister Kapil Sibal has urged Prime Minister Manmohan…
At a time when auctions for the 1,800 and 900 MHz spectrum bands failed due to high reserve price and…
The Supreme Court last week turned down Swiss drugmaker Novartis plea for patent protection.
Global pharma giants say they might go slow on research and development investments in India, post the Supreme Court?s denial…
